Affordable Access

Publisher Website

314. How the implementation of an in-vivo dosimetry protocol improved the dose delivery accuracy in radiotherapy?

Reports of Practical Oncology & Radiotherapy
Publication Date
DOI: 10.1016/s1507-1367(03)70797-4
  • Ecology
  • Medicine
  • Physics


The aim of this study was to check if the implementation of the institutional in-vivo dosimetry protocol improved the accuracy of the dose delivery in Radiotherapy. Material and Methods The dose evaluation was performed for the two groups of patients. First group consisted 812 patients treated from January 1st until June 30th, 2001. Composition of targets was: head and neck – 285 patients, breast – 138, gynaecology – 251 and the lung – 26. The second group consisted 1571 patients irradiated from February 1st, 2002 and included respectively: head and neck – 407, breast – 309, gynaecology – 681 and the lung – 309. Doses were calculated with the use of the Cadplan planning system and measured with semiconductor detectors: PTW Freiberg for photons 6–12 MV, Sun Nuclear Insured for photons 1–4 MV and 15–20 MV. The detectors were placed in a central axis at the entry. The institutional protocol implemented during the period between two evaluated groups of patients required that doses had to be measured during the first week of the treatment. The next measurement was performed in the middle of the radiotherapy course. Additional dose checks were done after any modification of the fields and on the request of the clinician or physicist. All fields were measured excluding the certain specific procedures. Measured doses were recalculated to the reference ICRU point using standard formulas. The following parameters were evaluated: N – the mean number of dose checks per patients, mean difference (in the groups) between measured Dm and calculated Dc doses: R=(Dm-Dc)/Dc*100% and SD – standard deviation (for one measurement). Results N= 4.9 vs. 6.0 (for the Ist vs. IInd group). The Mean R was respectively: −1.5% vs. −0.5% for head and neck; 3.4% vs. 2.2% for breast; 3.4% vs. 2.2% for gynaecology and −2.1% vs. 2.5% for the lung. The SD was respectively: 6.1% vs. 5.6% for head and neck; 5.8% vs. 5.4% for breast; 7.4% vs. 6.8% for gynaecology and 6.9% vs. 9.0% for the lung. The Shapiro-Wilk and Kolmogorov-Smirnov tests shoved for not normal distributions. Kolmogorov-Smirnov and Mann-Whitney U tests detected a significant difference between 1st and the IInd groups on the p=0.005 for head and neck, gynaecology and the lung while only at p=0.05 for the breast respectively. Conclusions The implementation of the institutional in-vivo dosimetry protocol increased significantly the compliance between measured and calculated doses excluding for the lung region.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times